Latest filing published 25 May 2023 for Infant Bacterial Therapeutics, €4,936.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Kronström: trading record in brief
Anders Kronström discloses dealings in Infant Bacterial Therapeutics to Finansinspektionen. In total, 2 filings cover trades dated from 20 May 2023 to 23 May 2023.
No open-market sale appears; the market trades are 2 purchases worth €12k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 25 May 2023 with an open-market purchase (€4,936) in Infant Bacterial Therapeutics. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Anders Kronström
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,329 shares@ SEK 42.505.1% of flowAktieISIN SE0008015259FI:csv-d9dd88e8695febcd41d1Canonical exit: 21 Aug 2023 (T+90)
- 25,000 shares@ SEK 3.297.5% of flowTeckningsoptionISIN SE0008015259FI:csv-1b2da8b1b16af3c01a75Canonical exit: 18 Aug 2023 (T+90)
2 of 2 declarations